Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Clin Genet ; 78(3): 201-18, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20497193

ABSTRACT

The 22q11.2 chromosomal landscape predisposes to genomic rearrangements that are associated with a variety of clinical phenotypes. The most well known of these include the 22q11.2 deletion and Cat-eye syndromes (CES), but more recently other copy number abnormalities have been recognised, especially with increased use of microarrays in the investigation of patients with congenital malformations or cognitive impairment. In addition, mutations in the TBX1 gene have been found in patients with phenotypes reminiscent of 22q11.2 syndromes. Recent advances in our understanding of 22q11.2 genes and their interactions provide insight into the mechanisms underlying the phenotypic variability of the 22q11.2 syndromes, and suggest a possible common developmental pathway perturbed by copy number abnormalities of this locus.


Subject(s)
Abnormalities, Multiple/genetics , Chromosome Aberrations , Chromosomes, Human, Pair 22/genetics , Abnormalities, Multiple/pathology , Animals , Craniofacial Abnormalities , Gene Expression Regulation, Developmental , Humans , Mutation , Syndrome , T-Box Domain Proteins/genetics
2.
Oral Dis ; 15(7): 437-53, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19583827

ABSTRACT

Orofacial clefts are the most common craniofacial birth defects and one of the most common congenital malformations in humans. They require complex multidisciplinary treatment and are associated with elevated infant mortality and significant lifelong morbidity. The development of craniofacial structures is an exquisitely orchestrated process involving the coordinated growth of multiple, independently derived primordia. Perturbations impacting on the genesis or growth of these primordia may interfere with the proper morphogenesis of facial structures, resulting in clefting of the lip, the primary or secondary palate, or a combination of these sites. A variety of genetic approaches involving both human populations and animal models have greatly facilitated the search for genes involved in human clefting. In this article, we review the most prominent genes for orofacial clefts in the context of developmental pathways that shape the craniofacial complex. We highlight several Mendelian clefting syndromes that have provided valuable clues in identifying genes for the more common, isolated forms of clefting. Finally, we elaborate on a number of potential subclinical features (subphenotypes) associated with what have previously been diagnosed as 'isolated' clefts that may serve as additional markers for identifying individuals or families in whom there may be a greater risk of inheriting a cleft.


Subject(s)
Cleft Lip/genetics , Cleft Palate/genetics , Animals , Cleft Lip/embryology , Cleft Palate/embryology , Facial Bones/embryology , Gene Expression Profiling , Gene Expression Regulation, Developmental , Genotype , Humans , Intercellular Signaling Peptides and Proteins/genetics , Maxillofacial Development/genetics , Phenotype , Transcription Factors/genetics
3.
J Med Genet ; 46(10): 649-56, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19473998

ABSTRACT

The involvement of SOX9 in congenital skeletal malformation was demonstrated 15 years ago with the identification of mutations in and around the gene in patients with campomelic dysplasia (CD). Translocations upstream of the coding sequence suggested that altered expression of SOX9 was capable of severely impacting on skeletal development. Subsequent studies in humans and animal models pointed towards a complex regulatory region controlling SOX9 transcription, involving approximately 1 Mb of upstream sequence. Recent data indicate that this regulatory domain may extend substantially further, with identification of several disruptions greater than 1 Mb upstream of SOX9 associated with isolated Pierre Robin sequence (PRS), a craniofacial disorder that is frequently a component of CD. The translocation breakpoints upstream of SOX9 can now be clustered into three groups, with a trend towards less severe skeletal phenotypes as the distance of each cluster from SOX9 increases. In this review we discuss how the identification of novel lesions surrounding SOX9 support the existence of tissue specific enhancers acting over a large distance to regulate expression of the gene during craniofacial development, and we highlight the potential for discovery of additional regulatory elements within the extended SOX9 control region.


Subject(s)
Gene Expression Regulation, Developmental , SOX9 Transcription Factor/genetics , Animals , Craniofacial Abnormalities/genetics , Enhancer Elements, Genetic , Female , Humans , Male , Mice , Musculoskeletal Abnormalities/genetics , SOX9 Transcription Factor/chemistry , SOX9 Transcription Factor/physiology , Testis/embryology , Testis/metabolism
5.
Dev Biol ; 229(2): 503-16, 2001 Jan 15.
Article in English | MEDLINE | ID: mdl-11150245

ABSTRACT

In situ hybridization revealed that GDNF mRNA in the mid- and hindgut mesenchyme of embryonic mice was minimal at E10.5 but was rapidly elevated at all gut regions after E11, but with a slight delay (0.5 days) in the hindgut. GDNF mRNA expression was minimal in the mesentery and in the pharyngeal and pelvic mesenchyme adjacent to the gut. To examine the effect of GDNF on enteric neural crest-derived cells, segments of E11.5 mouse hindgut containing crest-derived cells only at the rostral ends were attached to filter paper supports and grown in catenary organ culture. With GDNF (100 ng/ml) in the culture medium, threefold fewer neurons developed in the gut explants and fivefold more neurons were present on the filter paper outside the gut explants, compared to controls. Thus, in controls, crest-derived cells colonized the entire explant and differentiated into neurons, whereas in the presence of exogenous GDNF, most crest-derived cells migrated out of the gut explant. This is consistent with GDNF acting as a chemoattractant. To test this idea, explants of esophagus, midgut, superior cervical ganglia, paravertebral sympathetic chain ganglia, or dorsal root ganglia from E11.5-E12.5 mice were grown on collagen gels with a GDNF-impregnated agarose bead on one side and a control bead on the opposite side. Migrating neural cells and neurites from the esophagus and midgut accumulated around the GDNF-impregnated beads, but neural cells in other tissues showed little or no chemotactic response to GDNF, although all showed GDNF-receptor (Ret and GFRalpha1) immunoreactivity. We conclude that GDNF may promote the migration of crest cells throughout the gastrointestinal tract, prevent them from straying out of the gut (into the mesentery and pharyngeal and pelvic tissues), and promote directed axon outgrowth.


Subject(s)
Enteric Nervous System/embryology , Gene Expression Regulation, Developmental , Intestines/embryology , Nerve Growth Factors/genetics , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/pharmacology , Neurons/physiology , Animals , Cecum/embryology , Cecum/innervation , Cell Division/drug effects , Embryonic and Fetal Development , Glial Cell Line-Derived Neurotrophic Factor , Intestines/innervation , Mice , Nerve Growth Factors/pharmacology , Nerve Growth Factors/physiology , Nerve Tissue Proteins/physiology , Neurons/cytology , Neurons/drug effects , Organ Culture Techniques , RNA, Messenger/genetics , Transcription, Genetic
6.
Nat Genet ; 25(4): 414-8, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10932185

ABSTRACT

Secondary palate formation is a complex process that is frequently disturbed in mammals, resulting in the birth defect cleft palate. Gene targeting has identified components of cytokine/growth factor signalling systems such as Tgf-alpha/Egfr, Eph receptors B2 and B3 (Ephb2 and Ephb3, respectively), Tgf-beta2, Tgf-beta3 and activin-betaA (ref. 3) as regulators of secondary palate development. Here we demonstrate that the mouse orphan receptor 'related to tyrosine kinases' (Ryk) is essential for normal development and morphogenesis of craniofacial structures including the secondary palate. Ryk belongs to a subclass of catalytically inactive, but otherwise distantly related, receptor protein tyrosine kinases (RTKs). Mice homozygous for a null allele of Ryk have a distinctive craniofacial appearance, shortened limbs and postnatal mortality due to feeding and respiratory complications associated with a complete cleft of the secondary palate. Consistent with cleft palate phenocopy in Ephb2/Ephb3-deficient mice and the role of a Drosophila melanogaster Ryk orthologue, Derailed, in the transduction of repulsive axon pathfinding cues, our biochemical data implicate Ryk in signalling mediated by Eph receptors and the cell-junction-associated Af-6 (also known as Afadin). Our findings highlight the importance of signal crosstalk between members of different RTK subfamilies.


Subject(s)
Craniofacial Abnormalities/genetics , Receptor Cross-Talk/physiology , Receptor Protein-Tyrosine Kinases/metabolism , Animals , Animals, Newborn , Craniofacial Abnormalities/embryology , Embryonic and Fetal Development/genetics , Female , Genotype , Male , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Mice, Knockout , Mutation , Phenotype , Receptor Protein-Tyrosine Kinases/deficiency , Receptor Protein-Tyrosine Kinases/genetics , Receptor, EphB2 , Signal Transduction
7.
Hum Mol Genet ; 8(12): 2239-45, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10545604

ABSTRACT

Treacher Collins syndrome (TCS) is an autosomal dominant craniofacial disorder involving the mid and lower face and, in particular, the tissues affected arise solely from embryonic branchial arches I and II. TCOF1, the gene involved in TCS, has been cloned and although the function of the encoded protein, treacle, has not yet been established, it exhibits peak expression in the branchial arches. Treacle contains a series of repeating units of acidic and basic residues, which are predicted to contain putative casein kinase II (CKII) and protein kinase C (PKC) phosphorylation site motifs. In addition, treacle has weak homology to two phosphorylation-dependent nucleolar proteins, which shuttle between the cytoplasm and nucleolus. Based on these observations, phosphorylation of treacle may be important for its function. In this study, GST-treacle fusion peptides were constructed using particular TCOF1 exons that contained potential CKII and PKC phosphorylation sites. These were used as substrates in in vitro kinase assays and showed that treacle fusion peptides can be phosphorylated by the appropriate kinases. Furthermore, using tissue extracts we have demonstrated that in avian embryonic branchial arches I and II there is a kinase activity that can phosphorylate treacle peptides that is consistent with CKII site recognition. This activity coincides with the reported high expression of treacle in these tissues at early developmental stages and declines later in development.


Subject(s)
Branchial Region/enzymology , Mandibulofacial Dysostosis/genetics , Nuclear Proteins/genetics , Phosphoproteins/genetics , Phosphotransferases/metabolism , Animals , Base Sequence , Coturnix , DNA Primers , Glutathione Transferase/metabolism , Humans , Mandibulofacial Dysostosis/enzymology , Phosphorylation , Recombinant Fusion Proteins/genetics
8.
Dev Biol ; 213(1): 70-84, 1999 Sep 01.
Article in English | MEDLINE | ID: mdl-10452847

ABSTRACT

Cranial neural crest cell migration is patterned, with neural crest cell-free zones adjacent to rhombomere (R) 3 and R5. These zones have been suggested to result from death of premigratory neural crest cells via upregulation of BMP-4 and Msx-2 in R3 and R5, consequent to R2-, R4-, and R6-derived signals. We reinvestigated this model and found that cell death detected by acridine orange staining in avian embryos varied widely numerically and in pattern, but with a tendency for an elevated zone centered at the R2/3 boundary. In situ hybridization of BMP-4 mRNA resolved to centers at R3 and R5 but Msx-2 resolved to the R2/3 border with only a faint smear from R5 to R6. Outgrowth of neural crest cells was less in isolated R3 cultures than in R1+2, R2, and R4 cultures, but R3 showed neither a decrease in outgrowth of neural crest cells nor an increase in cell death when cocultured with R1+2, R2, or R4. In addition, in serum-free culture, exogenous BMP-4 strikingly reduced neural crest cell outgrowth from R1+2 and R4 as well as R3. Thus we cannot confirm the role of intraneural cell death in patterning rhombomeric neural crest outgrowth. However, grafting quail R2 or R4 adjacent to the chick hindbrain demonstrated a neural crest cell exclusion zone next to R3 and R5. We suggest that one important pattern determinant for rhombomeric neural crest cell migration involves the microenvironment next to the neural tube.


Subject(s)
Neural Crest/cytology , Rhombencephalon/embryology , Animals , Apoptosis/genetics , Body Patterning/genetics , Bone Morphogenetic Protein 4 , Bone Morphogenetic Proteins/genetics , Cell Movement , Chick Embryo , Coturnix , DNA-Binding Proteins/genetics , Gene Expression Regulation, Developmental , Homeodomain Proteins , In Situ Hybridization , Microscopy, Fluorescence , Neural Crest/metabolism , Rhombencephalon/cytology , Rhombencephalon/metabolism
9.
Oncogene ; 18(3): 679-88, 1999 Jan 21.
Article in English | MEDLINE | ID: mdl-9989818

ABSTRACT

In response to UV irradiation, mouse NIH3T3 fibroblasts transiently arrest predominantly in the G1 phase of the cell cycle. Here, we investigate the role of the retinoblastoma-related pocket proteins in this biological process. We report here that UV induces an increase in p107/E2F complexes, shown previously to be repressors of E2F-dependent transcriptional activity. Several lines of evidence indicate that the increase of p107/E2F complexes following UV irradiation is a consequence of rapid dephosphorylation of p107. First, UV-mediated p107 dephosphorylation could be abolished by pretreatment of NIH3T3 fibroblasts with the serine/threonine phosphatase inhibitors calyculin A and okadaic acid. Second, alteration of protein phosphatase 2A holoenzyme composition by over-expression of specific B subunits interfered with UV-mediated dephosphorylation of p107. Consistent with this, p107 could be dephosphorylated in vitro with PP2A. Moreover, dephosphorylation of p107 was shown to be independent of the activity of p53 and p21, as it occurred also in UV-treated p53-null as well as p21-null mouse fibroblasts. We observed a close correlation between the UV dosages required for G1 cell cycle arrest and p107 dephosphorylation. Our data suggest a model in which UV radiation-induced cell cycle arrest depends, at least in part, on the induction of a PP2A-like phosphatase that acts on p107.


Subject(s)
Carrier Proteins , Cell Cycle Proteins , DNA-Binding Proteins , Nuclear Proteins/metabolism , 3T3 Cells , Animals , Cell Line , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/genetics , Cyclins/physiology , E2F Transcription Factors , Enzyme Activation , Enzyme Inhibitors/pharmacology , G1 Phase , Humans , Marine Toxins , Mice , Okadaic Acid/pharmacology , Oxazoles/pharmacology , Phosphoprotein Phosphatases/antagonists & inhibitors , Phosphorylation , Protein Phosphatase 2 , Retinoblastoma-Binding Protein 1 , Retinoblastoma-Like Protein p107 , Substrate Specificity , Transcription Factor DP1 , Transcription Factors/metabolism , Tumor Cells, Cultured , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/physiology , Ultraviolet Rays
10.
Oncogene ; 13(5): 1073-82, 1996 Sep 05.
Article in English | MEDLINE | ID: mdl-8806697

ABSTRACT

We have previously shown in mouse NIH3T3 fibroblasts that transcription of the B-myb gene, which encodes a transcription factor required for S phase entry, is repressed through a promoter E2F site in G0/early G1. Transcription repression at this stage of the cell cycle was correlated with binding of a specific p107/E2F complex to this site. We report here, however, that transfection of cells with the known components of this complex, p107, E2F-4 and DP-1, did not repress the B-myb promoter in cycling NIH3T3 cells, although p107 inhibited transcription transactivation by E2F-4/DP-1. To establish definitively the contribution of E2F to repression, the effects of further mutations within and surrounding the E2F site were examined. It was evident that E2F binding and repression were closely correlated, lending greater weight to the contention that E2F itself is implicated in this activity. These studies also identified a closely linked site, designated the downstream repression site (DRS), which was not required for E2F binding or transactivation but which was necessary for repression. These findings indicated that E2F-dependent repression and activation are independently regulated phenomena and suggest that repression involves additional interactions determined by the promoter context.


Subject(s)
Carrier Proteins , Cell Cycle Proteins , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Proteins , Trans-Activators , Transcription Factors/genetics , Transcription Factors/metabolism , Transcriptional Activation , 3T3 Cells , Animals , Base Sequence , Binding Sites , Cell Cycle/genetics , E2F Transcription Factors , E2F4 Transcription Factor , Gene Expression Regulation , Genes, Suppressor , Mice , Mutation , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Phosphoproteins/metabolism , Promoter Regions, Genetic , Retinoblastoma-Binding Protein 1 , Retinoblastoma-Like Protein p107 , Retinoblastoma-Like Protein p130 , Transcription Factor DP1
11.
Proc Natl Acad Sci U S A ; 92(10): 4397-401, 1995 May 09.
Article in English | MEDLINE | ID: mdl-7753817

ABSTRACT

The bcl-2 protooncogene, which protects various cell types from apoptotic cell death, is expressed in the developing and adult nervous system. To explore its role in regulation of neuronal cell death, we generated transgenic mice expressing Bcl-2 under the control of the neuron-specific enolase promoter, which forced expression uniquely in neurons. Sensory neurons isolated from dorsal root ganglia of newborn mice normally require nerve growth factor for their survival in culture, but those from the bcl-2 transgenic mice showed enhanced survival in its absence. Furthermore, apoptotic death of motor neurons after axotomy of the sciatic nerve was inhibited in these mice. The number of neurons in two neuronal populations from the central and peripheral nervous system was increased by 30%, indicating that Bcl-2 expression can protect neurons from cell death during development. The generation of these transgenic mice suggests that Bcl-2 may play an important role in survival of neurons both during development and throughout adult life.


Subject(s)
Brain/physiology , Ganglia, Spinal/physiology , Gene Expression , Neurons, Afferent/physiology , Neurons/cytology , Neurons/physiology , Proto-Oncogene Proteins/biosynthesis , Proto-Oncogenes , Aging/physiology , Animals , Animals, Newborn , Apoptosis , Brain/cytology , Ganglia, Spinal/cytology , Humans , Mice , Mice, Transgenic , Motor Neurons/cytology , Motor Neurons/physiology , Neurons, Afferent/cytology , Promoter Regions, Genetic , Protein-Tyrosine Kinases/biosynthesis , Proto-Oncogene Proteins c-bcl-2 , Sciatic Nerve/physiology , Spinal Cord/cytology , Spinal Cord/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...